Attach to Form 990 or Form 990-EZ.
Information about Schedule A (Form 990 or 990-EZ) and its instructions is at www.irs.gov/form990.
| (i)Name of supported organization | (ii) EIN | (iii) Type of organization (described on lines 1- 9 above (see instructions)) | (iv) Is the organization listed in your governing document? | (v) Amount of monetary support (see instructions) | (vi) Amount of other support (see instructions) | |
|---|---|---|---|---|---|---|
| Yes | No | |||||
| (A)
GREATER KC COMM FNDTN |
431152398 | 8 | Yes | 0 | 0 | |
| Total 1 | 0 | 0 | ||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2011 | (b) 2012 | (c) 2013 | (d) 2014 | (e) 2015 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any unusual grants.) .... | ||||||
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf....... | ||||||
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 4 | Total. Add lines 1 through 3 | ||||||
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f).. | ||||||
| 6 | Public support. Subtract line 5 from line 4. | ||||||
Calendar year
(or fiscal year beginning in) ![]() |
(a) 2011 | (b) 2012 | (c) 2013 | (d) 2014 | (e) 2015 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | ||||||
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... | ||||||
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. | ||||||
| 11 | Total support. Add lines 7 through 10. | ||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2011 | (b) 2012 | (c) 2013 | (d) 2014 | (e) 2015 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") . | ||||||
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose...... | ||||||
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513... | ||||||
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | ||||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 6 | Total. Add lines 1 through 5. | ||||||
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons... | ||||||
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | ||||||
| c | Add lines 7a and 7b.. | ||||||
| 8 | Public support. (Subtract line 7c from line 6.) | ||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2011 | (b) 2012 | (c) 2013 | (d) 2014 | (e) 2015 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6... | ||||||
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | ||||||
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975. | ||||||
| c | Add lines 10a and 10b. | ||||||
| 11 | Net income from unrelated business activities not included in line 10b, whether or not the business is regularly carried on. | ||||||
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) .. | ||||||
| 13 | Total support. (Add lines 9, 10c, 11, and 12.).. | ||||||
| Section A - Adjusted Net Income | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Net short-term capital gain | 1 | ||||
| 2 | Recoveries of prior-year distributions | 2 | ||||
| 3 | Other gross income (see instructions) | 3 | ||||
| 4 | Add lines 1 through 3 | 4 | ||||
| 5 | Depreciation and depletion | 5 | ||||
| 6 | Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) | 6 | ||||
| 7 | Other expenses (see instructions) | 7 | ||||
| 8 | Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) | 8 | ||||
| Section B - Minimum Asset Amount | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): | 1 | ||||
| a | Average monthly value of securities | 1a | ||||
| b | Average monthly cash balances | 1b | ||||
| c | Fair market value of other non-exempt-use assets | 1c | ||||
| d | Total (add lines 1a, 1b, and 1c) | 1d | ||||
| e |
Discount claimed for blockage or other factors (explain in detail in Part VI): |
|||||
| 2 | Acquisition indebtedness applicable to non-exempt use assets | 2 | ||||
| 3 | Subtract line 2 from line 1d | 3 | ||||
| 4 | Cash deemed held for exempt use. Enter 1-1/2% of line 3 (for greater amount, see instructions). | 4 | ||||
| 5 | Net value of non-exempt-use assets (subtract line 4 from line 3) | 5 | ||||
| 6 | Multiply line 5 by .035 | 6 | ||||
| 7 | Recoveries of prior-year distributions | 7 | ||||
| 8 | Minimum Asset Amount (add line 7 to line 6) | 8 | ||||
| Section C - Distributable Amount | Current Year | |||||
| 1 | Adjusted net income for prior year (from Section A, line 8, Column A) | 1 | ||||
| 2 | Enter 85% of line 1 | 2 | ||||
| 3 | Minimum asset amount for prior year (from Section B, line 8, Column A) | 3 | ||||
| 4 | Enter greater of line 2 or line 3 | 4 | ||||
| 5 | Income tax imposed in prior year | 5 | ||||
| 6 | Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) | 6 | ||||
| Section D - Distributions | Current Year | |
|---|---|---|
| 1 Amounts paid to supported organizations to accomplish exempt purposes | ||
|
2
Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity |
||
| 3 Administrative expenses paid to accomplish exempt purposes of supported organizations | ||
| 4 Amounts paid to acquire exempt-use assets | ||
| 5 Qualified set-aside amounts (prior IRS approval required) | ||
| 6 Other distributions (describe in Part VI). See instructions | ||
| 7Total annual distributions. Add lines 1 through 6. | ||
|
8
Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions |
||
| 9 Distributable amount for 2015 from Section C, line 6 | ||
| 10 Line 8 amount divided by Line 9 amount | ||
| Section E - Distribution Allocations (see instructions) |
(i) Excess Distributions |
(ii) Underdistributions Pre-2015 |
(iii) Distributable Amount for 2015 |
|
|---|---|---|---|---|
|
1
Distributable amount for 2015 from Section C, line 6 |
||||
|
2
Underdistributions, if any, for years prior to 2015 (reasonable cause required--see instructions) |
||||
| 3 Excess distributions carryover, if any, to 2015: | ||||
| a | ||||
| b | ||||
| c | ||||
| d From 2013....... | ||||
| e From 2014....... | ||||
| fTotal of lines 3a through e | ||||
| g Applied to underdistributions of prior years | ||||
| h Applied to 2015 distributable amount | ||||
|
i
Carryover from 2010 not applied (see instructions) |
||||
| j Remainder. Subtract lines 3g, 3h, and 3i from 3f. | ||||
| 4Distributions for 2015 from Section D, line 7: | ||||
| $ | ||||
| a Applied to underdistributions of prior years | ||||
| b Applied to 2015 distributable amount | ||||
| c Remainder. Subtract lines 4a and 4b from 4. | ||||
|
5
Remaining underdistributions for years prior to 2015, if any. Subtract lines 3g and 4a from line 2 (if amount greater than zero, see instructions) |
||||
|
6
Remaining underdistributions for 2015. Subtract lines 3h and 4b from line 1 (if amount greater than zero, see instructions) |
||||
|
7 Excess distributions carryover to 2016. Add lines 3j and 4c. |
||||
| 8 Breakdown of line 7: | ||||
| a | ||||
| b | ||||
| c Excess from 2013....... | ||||
| d From 2014....... | ||||
| e From 2015....... | ||||
| Facts And Circumstances Test |
|---|
| Return Reference | Explanation |
|---|
| Software ID: | |
| Software Version: |
Attach to Form 990 or 990-EZ.
Information about Schedule O (Form 990 or 990-EZ) and its instructions is at| Return Reference | Explanation |
|---|---|
| FORM 990, PART III, LINE 4A | 2015 ACCOMPLISHMENTS: 1. REGIONAL LIFE SCIENCES STRATEGIC ASSESSMENT THE KANSAS CITY AREA LIFE SCIENCES INSTITUTE (KCALSI) ENGAGED DELOITTE TO EXECUTE A STRATEGIC ASSESSMENT OF THE REGIONAL LIFE SCIENCES IN 2015 THAT INCLUDED OVER 150 INTERVIEWS AND A SURVEY SENT TO OVER 1,200 PEOPLE IN THE REGION. THE PROCESS UTILIZED THE "COLLECTIVE IMPACT" MODEL FROM STANFORD AND WAS LED BY AN EXPERIENCED STEERING COMMITTEE COMPRISED OF COMMUNITY LEADERS. THE KANSAS CITY REGION WAS COMPARED TO 15 LIFE SCIENCE CLUSTERS AROUND THE GLOBE TO AVOID AN INSULAR VIEW, LOOKING AT BOTH DRIVERS OF CLUSTER ENHANCEMENT AND REGIONAL SCIENTIFIC STRENGTHS. ONE OUTCOME OF THE ASSESSMENT WAS A VISION STATING, "THE KANSAS CITY REGION IS A GLOBAL LEADER AT THE NEXUS OF HUMAN AND ANIMAL HEALTH BENEFITING ALL OUR CITIZENS AND THE ECONOMY." THE VISION IS ASPIRATIONAL, YET ALSO ACHIEVABLE, ALLOWING THE REGION TO LEVERAGE OPPORTUNITIES AT THE NEXUS OF HUMAN AND ANIMAL HEALTH AND REDUCE HEALTHCARE DISPARITIES. THESE NEXUS OPPORTUNITIES WILL BE DIFFERENT FOR EVERYONE AND WILL LIKELY RANGE FROM USING NATURALLY OCCURRING CANCER IN DOGS FOR ACCELERATING HUMAN DISCOVERIES TO DEVELOPING HEALTH IT AND BIOINFORMATICS APPROACHES FOR ANIMAL HEALTH. FOUR AREAS OF SCIENTIFIC STRENGTH WERE IDENTIFIED IN THE PATH TO 2025 REPORT INCLUDING ANIMAL HEALTH, CANCER RESEARCH AND CARE, NEUROSCIENCE, OUTCOMES RESEARCH AND HEALTH IT. EACH OF THESE FOUR AREAS HAS A WORKING GROUP THAT IS MEETING TO DISCUSS OBJECTIVES AND TIME-DRIVEN METRICS FOR SUCCESS. ADDITIONALLY, FOUR DRIVERS OF CLUSTER ENHANCEMENT WERE IDENTIFIED INCLUDING COLLABORATION, WORKFORCE DEVELOPMENT, CAPITAL FORMATION, AND MESSAGING AND MARKETING. FOR EACH OF THESE DRIVERS, A TASK FORCE HAS DEVELOPED SIMILAR GOALS TO THOSE OF THE SCIENTIFIC AREAS. THESE CLUSTER DRIVERS WILL BE CRITICAL FOR THE SUCCESS OF THE ENTIRE KANSAS CITY ECOSYSTEM, ENABLING THE REGION TO BE MORE GLOBALLY COMPETITIVE. 2. RESEARCH DEVELOPMENT GRANT PROGRAMS THE RESEARCH DEVELOPMENT GRANT PROGRAM WAS ONE OF KCALSI'S FIRST PROGRAMS AND CONTINUES TO BE ONE OF THE MOST SUCCESSFUL PROGRAMS. IN 2015 KCALSI FUNDED FOUR OUTCOMES RESEARCH GRANTS THROUGH BLUE-KC, IN PARTNERSHIP WITH BLUE CROSS, BLUE SHIELD OF KANSAS CITY, AND THREE GRANTS FOR CHILDHOOD GENETIC DISEASES THROUGH USING A GRANT FROM THE PAUL PATTON TRUST, TED C. MCCARTER, WILLIAM EVANS, JR., AND BANK OF AMERICA, N.A. TRUSTEES. ALL RESEARCHERS THAT SUBMIT A PROPOSAL RECEIVED A COMPLETE NIH-STYLE WRITTEN REVIEW REGARDLESS OF THEIR FUNDING STATUS SO THEY COULD IMPROVE FUTURE GRANT APPLICATIONS LOCALLY OR NATIONALLY. MOST IMPORTANTLY, THE FUNDING OF THEIR RESEARCH PROPOSALS HAS RESULTED IN AN OVER 850% RETURN ON INVESTMENT IN THE FORM OF ADDITIONAL GRANT DOLLARS THAT COME BACK TO THE COMMUNITY AND TO THE RESEARCHERS TO CONTINUE THEIR RESEARCH AND QUEST FOR NEW TREATMENTS AND BETTER PATIENT OUTCOMES. KCALSI WAS SUCCESSFUL THIS YEAR IN OBTAINING A NEW GRANT THROUGH THE VICTOR E. SPEAS FOUNDATION GRANT, BANK OF AMERICA, N.A., TRUSTEE TO FUND RESEARCH IN NEUROMUSCULAR DISEASES, REQUIRING INTER-INSTITUTIONAL COLLABORATION. 3. EDUCATION/WORKFORCE DEVELOPMENT KCALSI IDENTIFIED CRITICAL WORKFORCE DEVELOPMENT NEEDS WHEN KCALSI WAS FORMED AND HAVE WORKED IN THIS AREA FOR MANY YEARS. WORKFORCE DEVELOPMENT WAS IDENTIFIED IN THE PATH TO 2025 REPORT AS A THREAT AND WEAKNESS TO THE REGION'S LIFE SCIENCE CLUSTER. THERE IS A REMARKABLE EFFORT UNDERWAY ACROSS THE KANSAS CITY COMMUNITY CALLED KC RISING HTTP://KCRISING.COM THAT INCLUDES A SIGNIFICANT WORKFORCE DEVELOPMENT COMPONENT. TO AVOID THE RISK OF EFFORT DUPLICATION, KCALSI'S EFFORTS AND EXPERTISE ARE BEING INTEGRATED WITH KC RISING TO DEVELOP A REGIONAL PLAN OF ACTION. IN 2015 KCALSI PROVIDED THREE MAJOR TWO-DAY PROFESSIONAL EDUCATION PROGRAMS FOR THE ANIMAL HEALTH CORRIDOR, BIOINFORMATICS AND BRINGING INNOVATIVE IDEAS TO KANSAS CITY. THESE EVENTS ARE EXPLAINED IN MORE DETAIL IN ITEMS 4 -8. THE NEED FOR GREATER HIGH SCHOOL ENGAGEMENT WAS REITERATED IN THE PATH TO 2025 BY THE REGION'S WEAKNESS IN NATIONAL ADVANCED PLACEMENT SCORES. KCALSI CONTINUES TO WORK IN MANY STEM AREAS INCLUDING BIOGENEIUS WHICH IS THE ONLY INTERNATIONAL COMPETITIVE BIOSCIENCE PROGRAM FOR HIGH SCHOOL STUDENTS. KCALSI ALSO INCLUDED HIGH SCHOOL STUDENTS FROM THE REGION AT ALL OF THREE PROFESSIONAL EDUCATION PROGRAMS TO EXPOSE THEM TO BIOSCIENCE COMPANIES, NETWORKS AND MENTORS TO HELP THEM IN THE FUTURE. 4. ANIMAL HEALTH RESEARCH SYMPOSIUM TO RAISE THE RESEARCH PORTRAYAL OF THE KANSAS CITY REGIONAL ANIMAL HEALTH SECTOR, KCALSI EXPANDED THE ONE-DAY SYMPOSIUM TO A TWO-DAY EVENT IN PARTNERSHIP WITH THE SCHOOLS OF VETERINARY MEDICINE AT KANSAS STATE UNIVERSITY AND THE UNIVERSITY OF MISSOURI. THE AUGUST 30 - 31 EVENT ENTITLED "THE GROWING RISK OF ZOONOTIC AND VECTOR-BORNE DISEASES SYMPOSIUM" ATTRACTED 180 ATTENDEES FROM 13 STATES, AND INTERNALLY FROM THE UNITED KINGDOM, BRAZIL, GERMANY AND CANADA. THE TWO-DAY SYMPOSIUM FEATURED AN IMPRESSIVE SLATE OF 27 SPEAKERS COVERING TOPICS RANGING FROM EBOLA AND BOURBON TO EHRLICHIOSIS AND WAS DEVELOPED WITH THE EXPERTISE OF STEPHEN HIGGS, PHD, FRES, FASTMH, DIRECTOR OF THE BIORESEARCH INSTITUTE AT KANSAS STATE UNIVERSITY AND DANA VANLANDINGHAM, PHD. THE SYMPOSIUM WAS DESIGNED FOR PHYSICIANS, VETERINARIANS AND SCIENTISTS INTERESTED IN RESEARCH AND CLINICAL TOPICS OF ZOONOTIC AND VECTOR-BORNE DISEASES, INCLUDING NOVEL APPROACHES FOR DISEASE CONTROL. THE AGENDA FOCUSED ON FOUR OVERLAPPING AREAS: ZOONOTIC DISEASES VECTOR-BORNE DISEASES FOREIGN ANIMAL DISEASES VACCINES AND NOVEL APPROACHES FOR DISEASE CONTROL FEATURED SPEAKERS INCLUDE TAMMY BECKHAM, DVM, PHD, INCOMING DEAN OF THE K-STATE COLLEGE OF VETERINARY MEDICINE, WHO ADDRESSED CURRENT AND EMERGING INFECTIOUS DISEASE THREATS TO U.S. LIVESTOCK AND POULTRY INDUSTRIES. ADDITIONALLY, MICHELLE HAVEN, DVM, PHD, DACVS, ZOETIS SENIOR VICE PRESIDENT OF CORPORATE DEVELOPMENT, ALLIANCES, AND SOLUTIONS, SPOKE ABOUT A ONE HEALTH FOCUS TO INNOVATION AND ALLIANCES. SYMPOSIUM ABSTRACTS WERE PRINTED IN THE "VECTOR-BORNE AND ZOONOTIC DISEASES" SCIENTIFIC JOURNAL FOR THE FIRST TIME. 5. ANNUAL DINNER & "SCIENCE TO ART" AUCTION THE 2015 KCALSI ANNUAL DINNER, THEMED "SOLVING TODAY'S PROBLEMS WITH THE TECHNOLOGIES OF TOMORROW" WAS HELD AT THE ARVEST BANK THEATRE AT THE MIDLAND ON SEPTEMBER 30. OVER 520 ATTENDEES HEARD KEYNOTE SPEAKER, SALIM ISMAIL ADDRESSED THE CHALLENGES OF "SHIFTING FROM LINEAR TO EXPONENTIAL THINKING." SALIM, FOUNDING EXECUTIVE DIRECTOR AND GLOBAL AMBASSADOR OF SINGULARITY UNIVERSITY, AND AUTHOR OF EXPONENTIAL ORGANIZATIONS PRESENTED DATA TO HELP THE AUDIENCE APPRECIATE THE EXPONENTIAL MISSED OPPORTUNITIES OF KODAK AND IMPENDING OPPORTUNITIES IN HEALTH CARE, ENERGY, AND ARTIFICIAL INTELLIGENCE. SALIM ALSO DISCUSSED THE CHALLENGE OF INTEGRATING DISRUPTIVE TECHNOLOGIES INTO LARGE ESTABLISHED COMPANIES AND THE INTERNAL ANTIBODIES OF SUCH COMPANIES THAT ATTACK CHANGES TO THE CORE TECHNOLOGY. HIS ENTIRE PRESENTATION CAN BE VIEWED AT HTTP://WWW.KCLIFESCIENCES.ORG/EVENTS/ANNUAL-DINNER/. DURING THE EVENING, KCALSI BOARD CHAIRMAN, BILL BERKLEY, AND PRESIDENT AND CHIEF EXECUTIVE OFFICER, DR. WAYNE CARTER, PROVIDED AN OVERVIEW OF "PATH TO 2025," A 10-YEAR VISION AND PLAN THAT POSITIONS THE REGION AT THE NEXUS OF HUMAN AND ANIMAL HEALTH AND PROVIDES RECOMMENDED STEPS TO KEEP THE REGION GLOBALLY COMPETITIVE. THEY HIGHLIGHTED THE STRENGTHS IDENTIFIED IN THE REPORT AND WHERE OPPORTUNITIES EXIST FOR THE REGION TO DISTINGUISH ITSELF. THE COMPLETE REPORT IS AVAILABLE ONLINE AT HTTP://WWW.KCLIFESCIENCES.ORG/REPORTS/PATH-TO-2025/. THE 2015 "SCIENCE TO ART" SILENT AUCTION FEATURING THE INTRINSIC ART FOUND IN BIOMEDICAL RESEARCH WAS AGAIN A HUGE SUCCESS. SCIENTISTS FROM ACROSS THE REGION SUBMITTED IMAGES THAT WERE PROFESSIONALLY CURATED, PRINTED, AND FRAMED. ADDITIONALLY, A VIDEO HIGHLIGHTING THIS YEAR'S SCIENTISTS AND THEIR INCREDIBLE PASSION FOR STEAM (STEM AND ART) WAS SHOWN DURING THE DINNER AND CAN BE VIEWED AT HTTP://WWW.KCLIFESCIENCES.ORG/EVENTS/ANNUAL-DINNER/#SCIENCE-TO-ART-VIDE THE 2015 AUCTION YIELDED PROCEEDS OF $5,383. BECAUSE OF THE IMPORTANCE IN SUPPORTING EDUCATION AS IDENTIFIED IN "PATH TO 2025," KCALSI MATCHED THESE PROCEEDS TO MAKE OVER $10,000 AVAILABLE FOR "STEAM" EDUCATION, SPECIFICALLY BIOGENIUS, PREP-KC, SCIENCE PIONEERS, AND ARTIST, INC. 6. EXPONENTIAL KC FOLLOWING THE ANNUAL DINNER, KCALSI WITH THE SUPPORT OF THE KAUFFMAN FOUNDATION HELD A FULL DAY OF EXPONENTIAL LEARNING FOR COMMUNITY LEADERS CALLED EXPONENTIAL KC. THE PURPOSE OF EXPONENTIAL KC WAS TO EXPOSE COMMUNITY LEADERS AND ENTREPRENEURS TO THE OPPORTUNITIES THAT LIE WITHIN EXPONENTIAL TECHNOLOGIES. SALIM'S MESSAGE PRESENTED AT THE ANNUAL DINNER WAS ALIGNED WITH THE OCTOBER 1 EXPONENTIAL KC EVENT AND PROVIDED AN INSPIRING ARGUMENT FOR EXPONENTIAL THINKING AND OPPORTUNITIES. THE EXPONENTIAL KC EVENT BROKE MANY BARRIERS BUT MORE THAN ANYTHING WAS AN ENDEAVOR TO KEEP KANSAS CITY COMPETITIVE IN THE GLOBAL ECONOMY. IN LIEU OF A PRINTED PROGRAM KCALSI INTRODUCED A MOB |
| FORM 990, PART III, LINE 4A | (CONTINUED) 7. FIRST ANNUAL BIOINFORMATICS CONFERENCE KCALSI PARTNERED WITH UNIVERSITY OF MISSOURI-KANSAS CITY AND DR. MARK HOFFMAN, DIRECTOR FOR THE CENTER FOR HEALTH INSIGHTS, AND ASSOCIATE PROFESSOR IN BIOMEDICAL AND HEALTH INFORMATICS/PEDIATRICS TO HOLD THE FIRST ANNUAL MIDWEST BIOINFORMATICS CONFERENCE ON OCTOBER 15-16, 2015. THE TWO-DAY SYMPOSIUM WAS THE CULMINATION OF A RECOMMENDATION MADE IN A BIOINFORMATICS ASSESSMENT FUNDED BY THE KAUFFMAN FOUNDATION. THIS INAUGURAL CONFERENCE ATTRACTED OVER 170 ATTENDEES, AND WILL BECOME AN ANNUAL SYMPOSIUM WITH THE NEXT CONFERENCE PLANNED FOR THE SPRING OF 2017. A TOTAL OF 33 PROFESSIONALS, INCLUDING KEYNOTE SPEAKERS DR. JESSICA TENENBAUM OF THE DUKE TRANSLATIONAL MEDICINE INSTITUTE AND DR. CHRISTOPHER A. LONGHURST OF STANFORD CHILDREN'S HEALTH, PRESENTED THEIR EXPERTISE IN SEVEN THEMED DISCUSSION PANELS. THE PANELS CONSISTED OF FOUR BRIEF SPEAKER PRESENTATIONS FOLLOWED BY A DISCUSSION OF THE TOPICS PRESENTED. ONCE AGAIN, KCALSI EMPLOYED A MOBILE APPLICATION TO PROFILE THE CONFERENCE AGENDA, SPEAKER BIOGRAPHIES AND ABSTRACTS, AND ATTENDEE CONTACT INFORMATION. THE SYMPOSIUM'S POSTER SESSION ALLOWED 25 LOCAL BIOINFORMATICS RESEARCHERS TO PRESENT THEIR RESEARCH FINDINGS. THE CONFERENCE CONCLUDED WITH STUDENT MOCK INTERVIEWS, WITH EXPERTS FROM CERNER CORPORATION, CHILDREN'S MERCY HOSPITAL, AND BIOMED VALLEY DISCOVERIES PROVIDING 11 UNIVERSITY STUDENTS WITH INTERVIEW EXPERIENCE ESSENTIAL TO EMPLOYMENT WITHIN THE BIOINFORMATICS FIELD. 8. THIRD REGIONAL TRANSLATIONAL MEDICINE MEETING KCALSI ORGANIZED THE THIRD IN A SERIES OF MEETINGS DESIGNED TO ENHANCE REGIONAL COLLABORATIONS IN TRANSLATIONAL RESEARCH. THE 2015 REGIONAL TRANSLATIONAL MEDICINE MEETING WAS HELD ON APRIL 6-7 AT THE UNIVERSITY OF KANSAS IN LAWRENCE, KS. CLOSE TO 90 ATTENDEES ENJOYED HEARING PRESENTATIONS HIGHLIGHTING KU'S ASSETS. DAY ONE HIGHLIGHTED NEUROSCIENCE AND BIOINFORMATICS RESEARCHERS FOLLOWED BY TOURS OF CORE LABS IN THE MULTIDISCIPLINARY RESEARCH BUILDING AND SHANKEL STRUCTURAL BIOLOGY CENTER. THE BIOSCIENCE AND TECHNOLOGY BUSINESS CENTER (BTBC) INCUBATOR HOSTED A RECEPTION AND DINNER WITH FEATURED SPEAKERS, JULIE S. NAGEL, PHD, INTERIM PRESIDENT OF KU INNOVATION & COLLABORATION AND G.R. UNDERWOOD, BTBC'S PRESIDENT AND COO. DAY TWO WAS FILLED WITH RESEARCH HIGHLIGHTS IN PROTEIN STRUCTURE, VACCINE DEVELOPMENT, BIOENGINEERING, AND INFECTIOUS DISEASES AND CANCER. THE TWO-DAY EVENT CLOSED WITH TOURS OF THE HAWORTH HALL'S MICROSCOPY AND ANALYTICAL IMAGING, AND GENOMICS DEPARTMENTS. 9. HEARTLAND CIVIC COLLABORATIVE ASSET MAPPING CIVIC LEADERS FROM DES MOINES, KANSAS CITY, OMAHA, AND ST. LOUIS PARTNERED TO DEVELOP STRATEGIC, COORDINATED ACTIONS AIMED AT STRENGTHENING THE HEARTLAND'S COMPETITIVENESS IN THE GLOBAL ECONOMY. THE FOUR-STATE REGION SHARES A COMMON LIFE SCIENCES ECONOMY INCLUDING HUMAN, ANIMAL, AND PLANT SCIENCES. TO CATALOG SPECIFIC ASSETS, THE HEARTLAND CIVIC COLLABORATIVE CONDUCTED A FOUR-STATE LIFE SCIENCES ASSET MAPPING PROJECT IN 2015 WITH ST. LOUIS-BASED RUBIN BROWN, HTTP://HEARTLANDCIVICCOLLABORATIVE.ORG . THE STUDY IDENTIFIED 791 LIFE SCIENCES COMPANIES AT 976 LOCATIONS IN THE FOUR-STATE REGION. OF THOSE COMPANIES, 60% ARE HUMAN HEALTH, 15% AGRIBUSINESS, 15% ANIMAL HEALTH, 5% PLANT SCIENCES, AND 5% ENERGY. ADDITIONALLY, 389 UNIVERSITY RESEARCH INSTITUTES AND CENTERS WERE IDENTIFIED IN THE FOUR-STATE REGION FOR POTENTIAL COLLABORATION OPPORTUNITIES. EMPLOYMENT IN LIFE SCIENCES COMPANIES WAS ESTIMATED AT 82,800. THE DATA COMPILED THROUGH THE ASSET MAPPING PROJECT ALLOWS THE REGION TO: TARGET COMPANY RECRUITMENT AND ENHANCE COMPANY NETWORKS WITHIN SUB-SECTORS. INFORM STRATEGY DEVELOPMENT GUIDING ECONOMIC DEVELOPMENT ACTIVITIES. ENHANCE ACADEMIC-INDUSTRY PARTNERSHIPS FOR EFFICIENT COMMERCIALIZATION OF NEW INNOVATIONS. ENHANCE OPPORTUNITIES FOR SCIENTISTS TO ESTABLISH INTER-INSTITUTIONAL COLLABORATIONS. PROVIDE DATA REGARDING THE LIFE SCIENCES INDUSTRY TO SUPPORT ADVOCACY EFFORTS. THIS PROJECT BROUGHT TOGETHER A UNIQUE GROUP OF COLLABORATING ORGANIZATIONS AND REGIONS, INCLUDING THE BIOTECHNOLOGY INDUSTRY ORGANIZATION CHAPTERS IN EACH STATE (BIOKANSAS, BIONEBRASKA, IOWABIO, AND MOBIO); CIVIC AND SCIENCE ORGANIZATIONS (BIOSTL, CIVIC COUNCIL OF GREATER KANSAS CITY, GREATER DES MOINES PARTNERSHIP, GREATER OMAHA CHAMBER OF COMMERCE, KCALSI, AND MISSOURI TECHNOLOGY CORPORATION), AND THE PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA ASSOCIATION. 10. MEDICAL DEVICE NETWORK UNDER THE GUIDANCE OF DR. IVAN BROWN, CEO OF BROWNMED, KCALSI MANAGED AND FACILITATED THE MEDICAL DEVICE NETWORK - KANSAS CITY. IN APRIL, 2015, THE NETWORK'S WEBSITE - WWW.MDNKC.COM WAS LAUNCHED TO PROVIDE AN INTERACTIVE MAP REFLECTING THE VARIOUS MEDICAL DEVICE COMPANIES AND A SEARCHABLE COMPANY DIRECTORY. THE NEXT STAGE OF WEBSITE DEVELOPMENT WILL FEATURE A CAREER SECTION. THE MEDICAL DEVICE NETWORK'S QUARTERLY MEETINGS PROVIDED A VENUE FOR MEMBERS TO BENEFIT FROM BEST PRACTICE STANDARDS AND OFFER ACADEMIC STUDENTS AN OPPORTUNITY TO EXPLORE CAREER OPPORTUNITIES IN THE MEDICAL DEVICE ARENA. INSIGHT SHARED WITH THE MDN MEMBERSHIP IN 2015 INCLUDED LEVERAGING AND UNDERSTANDING INTELLECTUAL PROPERTY, STRATEGIC MARKET ENGAGEMENT, VENTURE CAPITAL FORMATION, AND PROCESSES CERNER USED TO DEVELOP 11 PATENTS AND FOUR CLOUD-APPLICATIONS. MEMBERSHIP TO THE MDN NOW REQUIRES THE COMPLETION OF AN APPLICATION. MEMBERSHIP APPLICATIONS CAN BE FOUND ONLINE AT MDNKC.COM. 11. 2015 KCALSI INDUSTRY CENSUS KCALSI HAS TRACKED THE REGION'S LIFE SCIENCES COMPANY INVENTORY EVERY THREE YEARS SINCE 2003. THE 2015 CENSUS IDENTIFIED 249 COMPANIES IN 24 COUNTIES EXTENDING FROM MANHATTAN, KS TO COLUMBIA, MO. THOSE COMPANIES CONSERVATIVELY EMPLOY OVER 28,000. ALTHOUGH THE NUMBER OF COMPANIES IN 2015 INCREASED SLIGHTLY OVER 2012, EMPLOYMENT IN THE REGION GREW AN IMPRESSIVE 20% SINCE THE LAST CENSUS. COMPANIES IN THE BIOTECHNOLOGY RESEARCH AND TESTING, AND DRUGS AND PHARMACEUTICALS INDUSTRY SEGMENTS ACCOUNT FOR 58% OF THE COMPANIES IN THE REGION, A LEVEL RELATIVELY UNCHANGED SINCE THE 2012 CENSUS. THESE TWO SEGMENTS EMPLOY OVER HALF THE TOTAL NUMBER OF LIFE SCIENCES WORKERS. HUMAN HEALTH-FOCUSED COMPANIES ACCOUNT FOR 66% OF THE COMPANIES IN THE REGION, REPRESENTING A STABLE PERCENTAGE IN 2009. ANIMAL HEALTH FOCUSED COMPANIES HAVE GROWN BY 6 COMPANIES OVER THE PAST THREE YEARS TO REACH 26% OF THE COMPANIES. PLANT AND CROP SCIENCE-FOCUSED COMPANIES REMAIN A SMALL PORTION (8%) OF THE TOTAL REGIONAL LIFE SCIENCES COMPANY PORTFOLIO. COPIES OF THE 2015 LIFE SCIENCES INDUSTRY CENSUS CAN BE DOWNLOADED FROM HTTP://WWW.KCLIFESCIENCES.ORG/ . 12. ECONOMIC DEVELOPMENT/COMMERCIALIZATION KCALSI RECOGNIZES THE VALUE OF ESTABLISHING INDUSTRY AND ACADEMIC COLLABORATIONS. AS NIH AND FEDERAL FUNDING DECREASE, INDUSTRY RESEARCH HOLDS TREMENDOUS OPPORTUNITY FOR THE KANSAS CITY REGION. IN ADDITION TO THE AFOREMENTIONED ACCOMPLISHMENTS, THE FOLLOWING ACTIVITIES REFLECT KCALSI'S EFFORTS TO ENRICH THE REGION'S LIFE SCIENCES ECOSYSTEM: KCALSI PARTICIPATED IN MENTORING AND EVALUATION TEAMS FOR BOTH THE DIGITAL SANDBOX AND SPRINT ACCELERATOR, THUS CONTRIBUTING TO THE SUCCESSFUL IDENTIFICATION OF HIGH-POTENTIAL COMPANIES FOR INVESTMENTS. KCALSI ALSO SUPPORTED THE CREATION OF AN ECOSYSTEM FOR MANY OF THESE COMPANIES BY LINKING THEM TO OTHER COMPANIES AND KCALSI'S TEN STAKEHOLDERS. KCALSI HAS DEVELOPED AN INCUBATOR NETWORK, A CONSORTIUM OF THE REGION'S WET AND DRY LABORATORY INCUBATORS, AND IS WORKING TO ENHANCE THE COLLECTIVE GROUP AS A REGIONAL ASSET AND SHARE BEST PRACTICES. IN RESPONSE TO AN URGENT NEED FOR REGIONAL STARTUP COMPANIES TO OBTAIN ACCESS TO CAPITAL AS IDENTIFIED IN THE PATH TO 2025 REPORT, KCALSI WORKED TO EDUCATE STATE LEGISLATORS REGARDING THE IMPORTANCE OF SUPPORTING STARTUP COMPANIES THROUGH VARIOUS PROGRAMS, INCLUDING ANGEL INVESTOR TAX CREDITS. A TASK FORCE, ACTING ON THE PATH TO 2025 REPORT, IS DIRECTLY WORKING ON THE MANY ISSUES OF CAPITAL FORMATION IN THIS REGION. |
| FORM 990, PART VI, SECTION A, LINE 2 | ANNE D. ST. PETER AND STEVEN ST. PETER,MD HAVE A FAMILY RELATIONSHIP. |
| FORM 990, PART VI, SECTION B, LINE 11 | THE ORGANIZATION HAS A POLICY FOR THE ORGANIZATION'S AUDIT COMMITTEE TO REVIEW THE 990 BEFORE IT IS FILED. |
| FORM 990, PART VI, SECTION B, LINE 12C | ALL STAFF AND DIRECTORS MUST SUBMIT ANY CONFLICTS OF INTEREST ON AN ANNUAL BASIS. IF A CONFLICT ARISES WITHIN THE BOARD, THE DISCLOSING INDIVIDUAL SHALL NEITHER VOTE NOR ENDEAVOR TO INFLUENCE THE DECISION. |
| FORM 990, PART VI, SECTION B, LINE 15A | COMPENSATION OF THE ORGANIZATION'S PRESIDENT IS AGREED UPON BY THE BOARD OF DIRECTORS AND FINALIZED VIA A WRITTEN EMPLOYMENT CONTRACT. THIS APPROVAL IS DOCUMENTED IN THE MINUTES OF THE BOARD. IN 2013 THE ORGANIZATION CREATED A COMPENSATION COMMITTEE AND HAS PLANNED A COMPENSATION STUDY TO FURTHER REFINE THE COMPENSATION PROCESS. |
| FORM 990, PART VI, SECTION C, LINE 19 | THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE ONLY AVAILABLE UPON REQUEST. |
| Software ID: | |
| Software Version: |